For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Ra Pharmaceuticals, Inc.

USPTO Granted Patents = 28

EPO Patents = 10

Trademarks = 3

Forward Citations = 75

Loading Chart...

Loading Chart...

51 inventors (with patents filed for the assignee):

Alonso Ricardo (27 out of 29 patents)

Douglas A Treco (21 out of 61 patents)

Zhong Ma (20 out of 20 patents)

4. Michelle Denise Hoarty (18 out of 18 patents)

5. Kristopher Josephson (17 out of 18 patents)

6. Nathan Ezekiel Nims (17 out of 17 patents)

7. Ping Ye (17 out of 18 patents)

8. Daniel Elbaum (16 out of 40 patents)

9. Zhaolin Wang (16 out of 26 patents)

10. Hong Zheng (16 out of 18 patents)

11. Kathleen Seyb (15 out of 17 patents)

12. Guo-Qing Tang (15 out of 15 patents)

13. Ketki Ashok Dhamnaskar (15 out of 15 patents)

14. Kelley Cronin Larson (12 out of 12 patents)

15. Sarah Jacqueline Perlmutter (12 out of 12 patents)

28 patents: Sort by Forward Citations

1. 12239684 - Modulators of complement activity (2025-03-04),

2. 12012468 - Cyclic polypeptides for PCSK9 inhibition (2024-06-18),

3. 11965040 - Modulation of complement activity (2024-04-23),

4. 11932705 - Cyclic polypeptides for PCSK9 inhibition (2024-03-19),

5. 11814445 - Cyclic polypeptides for PCSK9 inhibition (2023-11-14),

6. 11814444 - Cyclic polypeptides for PCSK9 inhibition (2023-11-14),

7. 11752190 - Modulators of complement activity (2023-09-12),

8. 11723949 - Modulators of complement activity (2023-08-15),

9. 11707503 - Modulators of complement activity (2023-07-25),

10. 11535650 - Modulation of complement activity (2022-12-27),

11. 11530244 - Cyclic polypeptides for PCSK9 inhibition (2022-12-20),

12. 11505575 - Cyclic polypeptides for PCSK9 inhibition (2022-11-22),

13. 11123399 - Modulators of complement activity (2021-09-21),

14. 11014965 - Modulation of complement activity (2021-05-25),

15. 10954287 - Ras binding peptides and methods of use (2021-03-23),

RA Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutics for the treatment of rare diseases. Their team of scientists is dedicated to bringing forth first-in-class and best-in-class therapies that can significantly improve the lives of patients. With a strong pipeline of potential drug candidates, RA Pharmaceuticals aims to address various unmet medical needs and make a positive impact on patient care.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

28 Patents

#77 in Cambridge, MA

#684 in Massachusetts

#11,610 in US

#22,565 in the World

Cambridge, MA, United States of America

Ra Pharmaceuticals, Inc.

Forward Citations = 75

51 inventors:

Alonso Ricardo (27 out of 29 patents)

Douglas A Treco (21 out of 61 patents)

Zhong Ma (20 out of 20 patents)

4. Michelle Denise Hoarty (18 out of 18 patents)

5. Kristopher Josephson (17 out of 18 patents)

Please report any incorrect information to support@idiyas.com

Loading…